This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/522136-eu-sues-astra-zeneca/
The article has changed 4 times. There is an RSS feed of changes available.
| Version 1 | Version 2 |
|---|---|
| EU sues AstraZeneca for under-delivering on Covid-19 vaccine contract | EU sues AstraZeneca for under-delivering on Covid-19 vaccine contract |
| (4 months later) | |
| The EU has commenced legal action against the Anglo-Swedish pharmaceutical company AstraZeneca, for under-delivering on vital Covid-19 shots, the European commissioner for health said in a tweet. | The EU has commenced legal action against the Anglo-Swedish pharmaceutical company AstraZeneca, for under-delivering on vital Covid-19 shots, the European commissioner for health said in a tweet. |
| In the tweet on Monday, Stella Kyriakides, the European commissioner for health and food safety, said that every vaccine counts in their efforts to save people against the deadly Covid-19 virus. | In the tweet on Monday, Stella Kyriakides, the European commissioner for health and food safety, said that every vaccine counts in their efforts to save people against the deadly Covid-19 virus. |
| “Our priority is to ensure #COVID19 vaccine deliveries take place to protect the health of [Europeans]. This is why @EU_Commission has decided jointly with all Member States to bring legal proceedings against AstraZeneca,” she tweeted. | “Our priority is to ensure #COVID19 vaccine deliveries take place to protect the health of [Europeans]. This is why @EU_Commission has decided jointly with all Member States to bring legal proceedings against AstraZeneca,” she tweeted. |
| Sources told Reuters and Politico last week that Brussels was mulling legal action against the pharmaceutical firm, which had vowed not to make a profit from the sale of Covid-19 jab during the pandemic. | Sources told Reuters and Politico last week that Brussels was mulling legal action against the pharmaceutical firm, which had vowed not to make a profit from the sale of Covid-19 jab during the pandemic. |
| AstraZeneca has dismissed the legal action as “without merit” and has vowed to defend itself in court. “AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible,” the company said in a statement. | AstraZeneca has dismissed the legal action as “without merit” and has vowed to defend itself in court. “AstraZeneca has fully complied with the Advance Purchase Agreement with the European Commission and will strongly defend itself in court. We believe any litigation is without merit and we welcome this opportunity to resolve this dispute as soon as possible,” the company said in a statement. |
| The EU’s decision comes after the company missed multiple contractual deadlines relating to the delivery of its Covid-19 vaccine. | The EU’s decision comes after the company missed multiple contractual deadlines relating to the delivery of its Covid-19 vaccine. |
| The company delivered 30 million jabs to the EU in the first quarter instead of the contracted 100 million. It is also projected to miss second-quarter delivery targets by a wide margin. | The company delivered 30 million jabs to the EU in the first quarter instead of the contracted 100 million. It is also projected to miss second-quarter delivery targets by a wide margin. |
| The vaccine has also faced scrutiny over very rare side effects, including potentially fatal blood clots, and resultantly its use has been limited across the bloc. Numerous highly critical comments have influenced the jab’s uptake, with some doctors in France claiming they’ve had to throw unused and now out-of-date shots away. | The vaccine has also faced scrutiny over very rare side effects, including potentially fatal blood clots, and resultantly its use has been limited across the bloc. Numerous highly critical comments have influenced the jab’s uptake, with some doctors in France claiming they’ve had to throw unused and now out-of-date shots away. |
| Last Friday, German Health Minister Jens Spahn dismissed the idea of suing the Anglo-Swedish firm, after the EU said it would need the support of all 27 nations before commencing legal action. | Last Friday, German Health Minister Jens Spahn dismissed the idea of suing the Anglo-Swedish firm, after the EU said it would need the support of all 27 nations before commencing legal action. |
| Speaking at a press conference on Thursday, a European Commission spokesman said that the EU had decided against taking up an option to buy 100 million more Covid-19 shots from AstraZeneca. | Speaking at a press conference on Thursday, a European Commission spokesman said that the EU had decided against taking up an option to buy 100 million more Covid-19 shots from AstraZeneca. |
| The EU has turned to Pfizer and Moderna to secure more shots, saying it would back “proven” vaccine technology in the fight against the virus. | The EU has turned to Pfizer and Moderna to secure more shots, saying it would back “proven” vaccine technology in the fight against the virus. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |